-
If you purchased shares of AmREIT Inc (NYSE:AMRE) and currently hold any of those NYSE:AMRE shares, you have certain options and you should contact the Shareholders Foundation, Inc.
-
To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Investigation Overview
November 11, 2014 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of AmREIT Inc (NYSE:AMRE), was announced concerning whether the takeover of AmREIT Inc by Edens Investment Trust for $26.55 per share is unfair to NYSE:AMRE stockholders.
The investigation by a law firm concerns whether certain officers and directors of AmREIT Inc breached their fiduciary duties owed to NYSE:AMRE investors in connection with the proposed acquisition.
On October 31, 2014, AmREIT, Inc. (NYSE:AMRE) announced that it has entered into an agreement with Edens Investment Trust under which Edens Investment Trust will acquire all outstanding shares of common stock of AmREIT for $26.55 per share in an all-cash transaction with a total enterprise value of approximately $763 million.
However, the investigation concerns whether the offer is unfair to NYSE:AMRE stockholders. More specifically, the investigation concerns whether the AmREIT Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.
AmREIT Inc reported that its annual Total Revenue rose from $36.72 million in 2011 to $47.20 million in 2013 and that its Net Income grea from $4.24 million in 2011 to $14.82 million in 2013. Shares of AmREIT Inc (NYSE:AMRE) grew from $14.00 per share in August 2012 to as high as $19.12 per share on July 8, 2014.
